Association Between Training Load and Lactate and Other Metabolites Analyzed by Metabolomic and Proteomic Techniques (PROTEOMET)

April 12, 2024 updated by: Fundació Eurecat

Evaluation of the Relationship Between Training Load and the Levels of Lactate and Other Metabolites Analyzed in Blood and Saliva Samples Using Metabolomic and Proteomic Techniques in Federated Basketball Players: Quasi-experimental Study

Physical exercise induces numerous changes in the body in a complex signalling network caused by or in response to increased metabolic activity of contracting skeletal muscles.

The application of omics analytical techniques such as proteomics and metabolomics in the field of sport allows us to understand how the human body responds to exercise and how sports results can be improved by optimising nutrition and training. Both omics techniques offer a quantitative measurement of the metabolic profiles associated with exercise and are able to identify metabolic signatures of athletes from different sports disciplines.

Basketball is a high-intensity exercise modality interspersed with low-intensity. The performance requirements of basketball include aerobic and anaerobic metabolism, with anaerobic metabolism being considered the main energy system. Therefore, basketball players need great athletic ability to produce a successful performance during competition.

For optimal sports performance it is important to adjust the training load, i.e. the degree of effort that the player can withstand in a single training session. Coaches require effective and objective load monitoring tools that allow them to make decisions about training plans based on the needs of each player.

Microsampling systems emerge as an alternative to venipuncture by facilitating self-sampling, which can be carried out outside healthcare centres, in a comfortable and precise way from a small finger prick that the user can perform. These systems are less expensive and can be effective in measuring the levels of glucose metabolism products, such as lactate, through the application of metabolomics and proteomics. On the other hand, the use of non-invasive methods of measuring lactate levels is becoming increasingly popular in sports medicine. The use of saliva as an alternative fluid to the blood shows promise for identifying the concentrations of metabolites that occur during and after sports training.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The study hypothesizes that the use of minimally invasive microsampling systems, and subsequent application of metabolomics and proteomics, will allow the detection of differences in the levels of lactate and other metabolites and proteins produced by the greater energy demand of the musculoskeletal system after a single collective training on the court, in federated basketball players. In addition, lactate levels will be correlated with the subjective sensation of perceived exertion.

The main objective of the study is to apply metabolomics techniques to analyze lactate levels in capillary blood samples collected by a dried blood spot (DBS) microsampling device, and to study their correlation with the subjective sensation of perceived effort in federated basketball players before and after performing a single collective training session on the court.

The secondary objectives of the study are to measure the change in lactate levels in capillary blood samples collected by a DBS device, and in saliva samples collected by a collector, before and after performing a single collective training on the court. In addition, in these samples, the change in the levels of other metabolomic and proteomic markers related to energy, lipid and amino acid metabolism will be measured. The correlation between salivary and blood lactate levels will also be studied; subjective sensation of perceived exertion and salivary lactate levels; the subjective sensation of perceived exertion and the levels of other metabolomic and proteomic markers will be also studied.

A single-group quasi-experimental (or pre-post) study will be carried out on 70 basketball players between the ages of 18 and 40.

Each participant will attend 2 visits to the sports facilities of their basketball club:

  • A recruitment and pre-selection visit (to check the eligibility criteria and sign the informed consent). If the inclusion criteria are met, will be scheduled to:
  • A single study visit on the same day agreed for training.

The main variable of the study is the correlation between lactate levels, measured in capillary blood pre- and post-training, and the subjective sensation of perceived effort.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Men and women, active players of the Catalan Basketball Federation and the Spanish Basketball Federation between 18 and 40 years old (both included).
  • Sign the informed consent.

Exclusion Criteria:

  • Present any metabolic disorder that may interfere with the objectives of the study (high blood pressure, diabetes, hypercholesterolemia or obesity; Body Mass Index (BMI) values ≥ 35 Kg/m2.
  • Suffer from disorders of glucose metabolism that may alter lactate synthesis, such as lactic acidosis, hyperlactatemia, or other metabolic acidosis.
  • Taking any type of medication that may alter metabolite or lactate levels.
  • Having belonephobia (phobia of needles).
  • Take ergogenic aids or supplements based on sucrose or glucose polymers before, during, or after training.
  • Being a smoker.
  • Being pregnant.
  • Breastfeeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-test and post-test measurements
Before and after a single collective training on the court. Collection of capillary blood and saliva samples; Completion of lifestyle questionnaires and sociodemographic and clinical factors; Anthropometric measurements.
Single basketball training session with fixed intensity and duration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between blood lactate levels and the subjective sensation of perceived effort
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Lactate concentration (μM) measured in capillary blood pre- and post- training. Four drops of capillary blood will be collected pre- and post-training by means of a puncture with a retractable lancet on the index, middle or ring finger, and deposited on a dried blood spot (DBS) "HemaXis DB10" card for analysis.

The subjective sensation of perceived effort will be assessed with the Perceived Exertion Index (RPE) measured post-training. This tool is used to monitor perceived effort during sports practice. It consists of a graduated scale from 0 to 10 where 0 is rest and 10 is maximum perceived effort.

Pre-training (baseline) and post-training (immediately after the training)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in saliva lactate levels
Time Frame: Pre-training (baseline) and post-training (immediately after the training)
A 15 mL Falcon tube will be used to collect the saliva sample by passive salivation. The lactate concentration in saliva will be analysed using the GC-qTOF technique.
Pre-training (baseline) and post-training (immediately after the training)
Change in blood lactate levels
Time Frame: Pre-training (baseline) and post-training (immediately after the training)
Lactate concentration (μM) measured in capillary blood collected in a dried blood spot card (DBS). The dried blood samples will be shipped to the analytical laboratory and analysed using combined analysis of liquid chromatography (UHPLC) coupled to triple quadrupole mass spectrometry (QqQ/MS) or quadrupole-time-of-flight mass spectrometry (qTOF/MS).
Pre-training (baseline) and post-training (immediately after the training)
Change in levels of lipid metabolic markers determined in capillary blood samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Lipid metabolic marker levels (described below) will be measured in capillary blood samples using the same DBS device as in the case of the primary outcome. Liquid chromatography (UHPLC 1290 Infinity II Series, Agilent Technologies) coupled to quadrupole - time of flight mass spectrometry (qTOF/MS 6546 Series, Agilent Technologies) will be used as metabolomic techniques.

Measured lipids: phosphatidylcholines, lysophosphatidylcholines, sphingomyelins, diglycerides, triglycerides, cholesterol esters, phosphatidylethanolamine and lysophosphatidylethanolamines.

All lipid metabolic markers in capillary bood will be reported in micromol (µM).

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of other lipid metabolic markers determined in capillary blood samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Lipid metabolic marker levels (described below) will be measured in capillary blood samples using the same DBS device as in the case of the primary outcome. Liquid chromatography (UHPLC 1290 Infinity II Series, Agilent Technologies) coupled to triple quadrupole mass spectrometry (QqQ/MS 6490 Series, Agilent Technologies) will be used as metabolomic techniques.

Measured lipids: oxylipins, non-esterified fatty acids, hormones, and acetylcarnitines.

All lipid metabolic markers in capillary blood will be reported in micromol (µM).

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of polar metabolites determined in capillary blood samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Polar metabolites (described below) will be measured in capillary blood samples using the same DBS device as in the case of the primary outcome. Gas chromatography coupled to quadrupole - time of flight mass spectrometry (GC-qTOF 7200 Series, Agilent Technologies) will be used as metabolomic techniques.

Measured polar metabolites: organic acids, amino acids, compounds related to energy metabolism and sugars.

All polar metabolites in capillary blood will be reported in micromol (µM).

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of lipid metabolic markers determined in saliva samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Lipid metabolic markers (described below) will be measured in saliva samples using a collection tube (15 mL Falcon tube). Gas chromatography coupled to quadrupole - time of flight mass spectrometry (GC-qTOF 7200 Series, Agilent Technologies) will be used as metabolomic techniques.

Measured lipids: phosphatidylcholines, lysophosphatidylcholines, sphingomyelins, diglycerides, triglycerides, cholesterol esters, phosphatidylethanolamine and lysophosphatidylethanolamines.

All lipid metabolic markers in saliva will be reported in micromol (µM).

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of other lipid metabolic markers determined in saliva samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Lipid metabolic marker levels (described below) will be measured in saliva samples using a collection tube (15 mL Falcon tube). Liquid chromatography (UHPLC 1290 Infinity II Series, Agilent Technologies) coupled to triple quadrupole mass spectrometry (QqQ/MS 6490 Series, Agilent Technologies) will be used as metabolomic techniques.

Measured lipids: oxylipins, non-esterified fatty acids, hormones, and acetylcarnitines.

All lipid metabolic markers in saliva will be reported in micromol (µM).

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of polar metabolites determined in saliva samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Polar metabolites (described below) will be measured in saliva samples using a collection tube (15 mL Falcon tube). Gas chromatography coupled to quadrupole - time of flight mass spectrometry (GC-qTOF 7200 Series, Agilent Technologies) will be used as metabolomic techniques.

Measured polar metabolites: organic acids, amino acids, compounds related to energy metabolism and sugars.

All polar metabolites in saliva will be reported in micromol (µM).

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of proteomic markers determined in capillary blood samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

Proteomic marker levels will be determined using the same DBS device as in the case of the primary outcome. The proteins in blood will be digested with trypsin to obtain peptides. The peptides will be analyzed by liquid nanochromatography coupled to mass spectrometry. The identification of the proteins will be carried out using the UniProt Homo Sapiens database using the Proteome Discoverer software (ThermoFisher Scientific).

All proteomic markers in capillary blood will be reported in arbitrary units as a relative unit of measurement.

Pre-training (baseline) and post-training (immediately after the training)
Change in levels of proteomic markers determined in saliva samples
Time Frame: Pre-training (baseline) and post-training (immediately after the training)

The proteins in saliva will be digested with trypsin to obtain peptides. The peptides will be analyzed by liquid nanochromatography coupled to mass spectrometry. The identification of the proteins will be carried out using the UniProt Homo Sapiens database using the Proteome Discoverer software (ThermoFisher Scientific).

All proteomic markers in saliva will be reported in arbitrary units as a relative unit of measurement.

Pre-training (baseline) and post-training (immediately after the training)
Pittsburgh Sleep Quality Index
Time Frame: Pre-training (baseline)
It is a validated scale that measures the usual sleep habits during the past month. It consists of 7 areas: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. It contains a total of 19 items, grouped into 10 questions where each of the areas evaluated is scored between 0 and 3. The scores from the seven areas are finally added up to give an overall score. The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Pre-training (baseline)
Heart rate variations
Time Frame: During the training
It will be measured, in bpm, in real time throughout training using an optical heart rate sensor (Polar Verity Sense) fitted to the left arm of each player with a textile elastic armband. The device monitors heart rate in real time. The average heart rate will be calculated with the data collected throughout the training.
During the training
Sociodemographic data: age and birth date
Time Frame: Pre-training (baseline)
Age will be recorded in years, and birth date in the format DD/MM/YYYY. It will be recorded in the case report form.
Pre-training (baseline)
Sociodemographic data: sex
Time Frame: Pre-training (baseline)
Sex will be recorded as male or female in the case report form.
Pre-training (baseline)
Lifestyle data: weekly training load
Time Frame: Pre-training (baseline)
Weekly training load will be recorded as hours/week in the case report form.
Pre-training (baseline)
Lifestyle data: playing position
Time Frame: Pre-training (baseline)
Playing position, will be recorded as base, shooting guard, small forward, power forward or center in the case report form.
Pre-training (baseline)
Clinical data: use of supplementation
Time Frame: Pre-training (baseline)
Use of supplementation will be recorded in the case report form.
Pre-training (baseline)
Clinical data: use of medication
Time Frame: Pre-training (baseline)
Use of medication will be recorded in the case report form.
Pre-training (baseline)
Clinical data: previous muscle injuries
Time Frame: Pre-training (baseline)
Previous muscle injuries will be recorded in the case report form.
Pre-training (baseline)
Physiological data
Time Frame: Pre-training (baseline)
Physiological data, including presence of current menstruation in women, will be recorded in the case report form.
Pre-training (baseline)
Anthropometric data: weight
Time Frame: Pre-training (baseline)
Weight will be measured in kg with a portable digital scale (Beuer b180) and recorded in the case report form.
Pre-training (baseline)
Anthropometric data: height
Time Frame: Pre-training (baseline)
Height will be measured in cm with a portable stadiometer and recorded in the case report form.
Pre-training (baseline)
Anthropometric data: body mass index
Time Frame: Pre-training (baseline)
Body mass index will be recorded in kg/m² in the case report form.
Pre-training (baseline)
Anthropometric data: fat mass percentage
Time Frame: Pre-training (baseline)
Fat mass percentage (%) will be measured with a portable digital scale (Beuer b180) and recorded in the case report form.
Pre-training (baseline)
Anthropometric data: muscle mass percentage
Time Frame: Pre-training (baseline)
Muscle mass percentage (%) will be measured with a portable digital scale (Beuer b180) and recorded in the case report form.
Pre-training (baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nuria Canela, PhD, Fundació Eurecat, Center for Omic Sciences
  • Study Director: Antoni Caimari, PhD, Fundació Eurecat, Biotechnology Area

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

March 25, 2024

First Submitted That Met QC Criteria

April 12, 2024

First Posted (Estimated)

April 15, 2024

Study Record Updates

Last Update Posted (Estimated)

April 15, 2024

Last Update Submitted That Met QC Criteria

April 12, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PROTEOMET

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lactate

Clinical Trials on Single basketball training

3
Subscribe